Rentschler Biopharma Promotes Patrick Meyer to Global Head of Business Development

Rentschler Biopharma SE, a prominent contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced Patrick Meyer, Ph.D., as the new Global Head of Business Development. With immediate effect, Dr. Meyer will lead the business development team and shape the company's global commercial strategy. He joins the Executive Committee, reporting directly to CEO Benedikt von Braunmühl.

Dr. Meyer, with over eight years at Rentschler, recently served as Global Head BD Sales and Alliance Management. His extensive experience in managing key accounts and strategic partnerships prepares him for this role. He aims to develop solutions focused on client challenges, creating meaningful impacts through innovative biopharmaceuticals.

Rentschler Biopharma demonstrates a commitment to internal talent development, highlighting its strategic focus on value creation and sustainable partnerships in the biopharmaceutical sector.